What brand name is Valsartan/Sacubitril marketed under?

Valsartan/Sacubitril is marketed under the brand name Entresto. This medication combines an angiotensin receptor blocker (valsartan) with a neprilysin inhibitor (sacubitril) to improve heart function and decrease the risk of hospitalization for heart failure. The unique mechanism of action of this combination allows for specific therapeutic benefits, particularly in patients with heart failure with reduced ejection fraction.

Entresto has been widely recognized for its efficacy in clinical trials, showcasing significant improvements in cardiovascular outcomes compared to standard treatments. Its distinct formulation sets it apart from the other choices, which include medications for various other conditions; for example, Cardizem is primarily used for hypertension and angina, Norvasc is a calcium channel blocker for hypertension and angina, and Lisinopril is an ACE inhibitor commonly prescribed for high blood pressure and heart failure. Each of those alternatives serves different therapeutic purposes and does not contain the same active ingredients as Valsartan/Sacubitril.